ALC vs BCRX
Alcon Inc vs BioCryst Pharmaceuticals, Inc. — AI-powered side-by-side comparison
VS
BCRX
BioCryst Pharmaceuticals, Inc.
55
Watch
| Metric | ALC | BCRX |
|---|
| AI Score |
68
|
55
|
| Price |
$75.39
|
$10.35
|
| P/E Ratio |
45.39×
|
-7.19×
|
| ROE |
4.4%
|
-221.4%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
54.9%
|
23.5%
|
| Debt / Equity |
0.24×
|
-0.90×
|
| Dividend Yield |
0.5%
|
0.0%
|
| RSI (14) |
73.4
|
75.0
|
| Beta |
0.703
|
0.554
|
| Expected Upside |
+11.3%
|
—
|
AI Committee View
Current Innellis committee reasoning for ALC versus BCRX.
ALC leads by 13 points.
ALC scores 68/100 (Buy) versus BCRX at 55/100 (Watch).
ALC Committee View
75% agreement
4 analysts
The primary driver is quarter-over-quarter growth rate is accelerating, not just positive. The main limiting factor is rsi at 73 is in overbought territory. The committee is constructive but not yet at full conviction.
Bull Case
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- MACD histogram positive -- bullish momentum — Technical
- VIX regime is low -- calm backdrop supports risk-taking — Macro
Bear Case
- RSI at 73 is in overbought territory — Technical
- Price trading above the upper Bollinger Band -- stretched — Technical
BCRX Committee View
33% agreement
6 analysts
The committee is genuinely divided. Growth Analyst sees a compelling case — revenue growing 68.7% yoy -- genuine top-line momentum. Risk Analyst remains cautious — high leverage (debt-to-equity 2.09) amplifies downside in a stress scenario. This disagreement is itself the signal — the setup is not clean in either direction.
Bull Case
- Revenue growing 68.7% YoY -- genuine top-line momentum — Growth
- Price structure making higher highs and higher lows — Technical
- MACD histogram positive -- bullish momentum — Technical
Bear Case
- Price-to-book of 13.9x prices in significant intangible value — Value
- ROE of only -328.8% -- cheap may mean cheap for a reason — Value
- Debt-to-equity of 2.09 adds balance-sheet risk to the value case — Value